183 related articles for article (PubMed ID: 32602366)
1. Contrast of Mastoscopic and Conventional Axillary Lymph Node Dissection of Patients With Breast Cancer: Meta-Analysis.
Xiong H; Chen Z; Xu L; Chen C; Fu Q; Teng R; Chen J; Xie S; Wang L; Yu XF; Zhou J
Cancer Control; 2020; 27(2):1073274820932987. PubMed ID: 32602366
[TBL] [Abstract][Full Text] [Related]
2. Comparison of mastoscopic and conventional axillary lymph node dissection in breast cancer: long-term results from a randomized, multicenter trial.
Luo C; Guo W; Yang J; Sun Q; Wei W; Wu S; Fang S; Zeng Q; Zhao Z; Meng F; Huang X; Zhang X; Li R; Ma X; Luo C; Yang Y
Mayo Clin Proc; 2012 Dec; 87(12):1153-61. PubMed ID: 23146657
[TBL] [Abstract][Full Text] [Related]
3. 17-Year Follow-up of Comparing Mastoscopic and Conventional Axillary Dissection in Breast Cancer: A Multicenter, Randomized Controlled Trial.
Luo C; Wei C; Guo W; Yang J; Sun Q; Wei W; Wu S; Fang S; Zeng Q; Zhao Z; Meng F; Huang X; Zhang X; Li R; Ma X; Luo C; Yang Y
Adv Ther; 2022 Jun; 39(6):2961-2970. PubMed ID: 35486221
[TBL] [Abstract][Full Text] [Related]
4. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
Sávolt Á; Péley G; Polgár C; Udvarhelyi N; Rubovszky G; Kovács E; Győrffy B; Kásler M; Mátrai Z
Eur J Surg Oncol; 2017 Apr; 43(4):672-679. PubMed ID: 28139362
[TBL] [Abstract][Full Text] [Related]
5. Feasibility analysis of treating breast cancer patients with breast-conserving surgery via a periareolar incision combined with non-lipolytic suspension-type mastoscopy.
Liu J; He G; Zhang Y; Wong MP; Chu J; Kong L; Yahya MM
Sci Rep; 2023 Jul; 13(1):12129. PubMed ID: 37495629
[TBL] [Abstract][Full Text] [Related]
6. [Mastoscopic axillary lymph node dissection for the patients with breast cancer].
Luo CY; Zhang J; Lin H; Yang Q; Huang X; Xue L; Zhang YZ; Li GH
Zhonghua Yi Xue Za Zhi; 2003 Nov; 83(22):1946-8. PubMed ID: 14703427
[TBL] [Abstract][Full Text] [Related]
7. A Population-Based Study of the Effects of a Regional Guideline for Completion Axillary Lymph Node Dissection on Axillary Surgery in Patients with Breast Cancer.
Tsao MW; Cornacchi SD; Hodgson N; Simunovic M; Thabane L; Cheng J; O'Brien MA; Strang B; Mukherjee SD; Lovrics PJ
Ann Surg Oncol; 2016 Oct; 23(10):3354-64. PubMed ID: 27342830
[TBL] [Abstract][Full Text] [Related]
8. Axillary recurrence in breast cancer patients with isolated tumor cells in the sentinel lymph node [AJCC N0(i+)].
Degnim AC; Zakaria S; Boughey JC; Sookhan N; Reynolds C; Donohue JH; Farley DR; Grant CS; Hoskin T
Ann Surg Oncol; 2010 Oct; 17(10):2685-9. PubMed ID: 20390457
[TBL] [Abstract][Full Text] [Related]
9. A standardized surgical technique for mastoscopic axillary lymph node dissection.
Chengyu L; Yongqiao Z; Hua L; Xiaoxin J; Chen G; Jing L; Jian Z
Surg Laparosc Endosc Percutan Tech; 2005 Jun; 15(3):153-9. PubMed ID: 15956900
[TBL] [Abstract][Full Text] [Related]
10. Comparing Observation, Axillary Radiotherapy, and Completion Axillary Lymph Node Dissection for Management of Axilla in Breast Cancer in Patients with Positive Sentinel Nodes: A Systematic Review.
Castelo M; Hu SY; Dossa F; Acuna SA; Scheer AS
Ann Surg Oncol; 2020 Aug; 27(8):2664-2676. PubMed ID: 32020394
[TBL] [Abstract][Full Text] [Related]
11. Factors that determine whether a patient receives completion axillary lymph node dissection after a positive sentinel lymph node biopsy for breast cancer in British Columbia.
Aslani N; Swanson T; Kennecke H; Woods R; Davis N
Can J Surg; 2011 Aug; 54(4):237-42. PubMed ID: 21651836
[TBL] [Abstract][Full Text] [Related]
12. Experience of a large series of mastoscopic axillary lymph node dissection.
Chengyu L; Jian Z; Xiaoxin J; Hua L; Qi Y; Chen G
J Surg Oncol; 2008 Aug; 98(2):89-93. PubMed ID: 18484080
[TBL] [Abstract][Full Text] [Related]
13. The evolution of the sentinel node procedure in the treatment of breast cancer.
Tvedskov TF
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975889
[TBL] [Abstract][Full Text] [Related]
14. Subsequent axillary surgery after sentinel lymph node biopsy: results from the BreastSurgANZ Quality Audit 2006-2010.
Chong C; Walters D; de Silva P; Taylor C; Spillane A; Kollias J; Pyke C; Campbell I; Maddern G
Breast; 2013 Dec; 22(6):1215-9. PubMed ID: 24157405
[TBL] [Abstract][Full Text] [Related]
15. Axillary lymph node dissection versus sentinel lymph node biopsy alone for early breast cancer with sentinel node metastasis: A meta-analysis.
Li CZ; Zhang P; Li RW; Wu CT; Zhang XP; Zhu HC
Eur J Surg Oncol; 2015 Aug; 41(8):958-66. PubMed ID: 26054706
[TBL] [Abstract][Full Text] [Related]
16. Axillary recurrence after a tumor-positive sentinel lymph node biopsy without axillary treatment: a review of the literature.
Francissen CM; Dings PJ; van Dalen T; Strobbe LJ; van Laarhoven HW; de Wilt JH
Ann Surg Oncol; 2012 Dec; 19(13):4140-9. PubMed ID: 22890590
[TBL] [Abstract][Full Text] [Related]
17. Altered lymphatic drainage patterns in re-operative sentinel lymph node biopsy for ipsilateral breast tumor recurrence.
Sato A; Sakai T; Iwase T; Kano F; Kimura K; Ogiya A; Koizumi M; Tanabe M; Horii R; Akiyama F; Ueno T; Ohno S
Radiat Oncol; 2019 Sep; 14(1):159. PubMed ID: 31477153
[TBL] [Abstract][Full Text] [Related]
18. [Standardized skill of mastoscopic axillary lymph node dissection].
Luo CY; Ji XX; Zhang J; Lin H; Yang Q; Guan C
Zhonghua Wai Ke Za Zhi; 2005 Jan; 43(1):21-4. PubMed ID: 15774168
[TBL] [Abstract][Full Text] [Related]
19. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
[TBL] [Abstract][Full Text] [Related]
20. Lymph node metastasis in patients with frozen section analyses that are negative for tumors.
Lee SK; Lee KW; Kim S; Choi MY; Kim J; Lee J; Jung SP; Choe JH; Kim JH; Kim JS; Lee JE; Yang JH; Nam SJ
Oncology; 2012; 83(1):31-7. PubMed ID: 22722529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]